IgG3 and IL10 are effective biomarkers for monitoring therapeutic effectiveness in Post Kala-Azar Dermal Leishmaniasis.
<h4>Background</h4>The assessment of chemotherapeutic responses in Post Kala-azar Dermal Leishmaniasis (PKDL), especially its macular form is challenging, emphasizing the necessity for 'test of cure' tools. This study explored the diagnostic and prognostic potential of IgG subc...
Main Authors: | Shilpa Sengupta, Mitali Chatterjee |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-11-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | https://doi.org/10.1371/journal.pntd.0009906 |
Similar Items
-
Immune responses in post kala-azar dermal leishmaniasis
by: Mitali Chatterjee, et al.
Published: (2020-01-01) -
Post kala-azar dermal leishmaniasis: Clinical features and differential diagnosis
by: Piyush Kumar, et al.
Published: (2021-01-01) -
Kala-azar and Post–Kala-azar Dermal Leishmaniasis, Assam, India
by: Abdul Mabood Khan, et al.
Published: (2014-03-01) -
Post kala-azar dermal leishmaniasis
by: Nilay Kanti Das
Published: (2020-01-01) -
Evaluation of Recombinase Polymerase Amplification assay for monitoring parasite load in patients with kala-azar and post kala-azar dermal leishmaniasis
by: Madhurima Roy, et al.
Published: (2023-04-01)